Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Afamelanotide (Scenesse) is the FDA-approved pharmaceutical formulation with proven safety and efficacy from Phase 3 clinical trials, delivered as a controlled-release subcutaneous implant
Dear User While we work to ensure that product information is correct, on occasion manufacturers may alter their ingredient lists
Unlike semaglutide and tirzepatide, which can be compounded because they have FDA-approved reference products, retatrutide has no approved form to compound from
occasional mild side effects may include injectionsite reactions (redness, swelling), transient flushing, or headache [11]
US$ 22.92
US$ 24.98
US$ 28.89
